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HTLV-1 carriers and the patients with adult T-cell
leukemia (ATL) frequently suffer from the opportunis-
tic infections. Although it has been known that HTLV-
1 infection evokes cell-mediated immune deficiency, its
mechanism remains unknown. HTLV-1 bZIP factor
(HBZ) is encoded in the minus strand of HTLV-1,
which is constitutively expressed and involved in the
proliferation of HTLV-1-infected cells. In this study,
we investigated the role of HBZ in immunodeficiency
in a mice model. HBZ transgenic (HBZ-Tg) mice were
infected with HSV-2 and Listeria monocytogenes and
evaluated for cellular immunity to those pathogens.
The clearance of both pathogens was impaired in
HBZ-Tg mice compared with the non-transgenic litter-
mate. In the both infection, production of IFN-gamma
in CD4+ T cells was significantly reduced in HBZ-Tg
mice. In addition, ectopic expression of HBZ in pri-
mary human CD4+ T cells impaired IFN-gamma pro-
d u c t i o ni nv i t r o .A st h em o l e c u l a rm e c h a n i s m s ,w e
found that HBZ suppressed transcription of IFNG pro-
moter. Our results suggestt h a tH B Zp l a y sac r u c i a l
role for cellular immunodeficiency in HTLV-1-infected
subjects.
Author details
1Laboratory of Virus Control, Institute for Virus Research, Kyoto University,
Kyoto, Japan.
2Department of Hematology, Kumamoto University School of
Medicine, Japan.
Published: 6 June 2011
doi:10.1186/1742-4690-8-S1-A102
Cite this article as: Sugata et al.: HTLV-1 bZIP factor perturbs immune
response to the pathogens in vivo by inhibiting IFN-gamma
production. Retrovirology 2011 8(Suppl 1):A102.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
* Correspondence: mmatsuok@virus.kyoto-u.ac.jp
1Laboratory of Virus Control, Institute for Virus Research, Kyoto University,
Kyoto, Japan
Full list of author information is available at the end of the article
Sugata et al. Retrovirology 2011, 8(Suppl 1):A102
http://www.retrovirology.com/content/8/S1/A102
© 2011 Sugata et al; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.